Abstract
Article AbstractThe article in this issue by Hampel et al1 offers a glimpse of an interesting chapter in the history of Alzheimer's disease (AD) treatment research. An understanding of the significance of this report, which touches on issues ranging from the identification of novel targets for treatment to widely differing approaches to trial design, provides an appreciation of the rapid pace of treatment development in the field and allows one to gain some insight into an interesting historical sidebar. Alzheimer's disease is now the fourth leading cause of death in people over age 65 years in the United States and the only major cause of death that is increasing over time.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
